Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Actuate Therapeutics, Inc. - Common stock (NQ: ACTU )

7.460 +0.452 (+6.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,761
Open 6.950
Bid (Size) 2.960 (2)
Ask (Size) 7.460 (20)
Prev. Close 7.008
Today's Range 6.365 - 7.500
52wk Range 5.510 - 10.16
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pheton, Powell Max Make Public Debut
Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic... 
Via Talk Markets
Actuate Therapeutics Makes Public Debut
Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share. 
Via Talk Markets

Performance

YTD
-13.36%
-13.36%
1 Month
-8.47%
-8.47%
3 Month
-13.36%
-13.36%
6 Month
-13.36%
-13.36%
1 Year
-13.36%
-13.36%

More News

Read More
InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.